http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-11201900930U-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46cb3dfdd38a34ce27bf0e2323d90a6a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-01017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L27-33
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L2-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L27-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-01017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1051
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-60
filingDate 2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f6501ea0fb0d1ef3c85f49eb5475624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b774332660d9f8cf91814e0fb9c7457
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfaddc9765510214bf3d154e791787f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4f84a35bc0557a6c2273b7e633cdb74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55a1ae9c33cff2e6b72b7d4f41eb421b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ae0d7672fd0fcf304ee67d3aa5f6792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e8f3756c924bca3702b771fb036d6bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7867364139a4ed2f95d7878fe1c8f362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ab6b92bf251a1eba22bd118f9408b7d
publicationDate 2019-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SG-11201900930U-A
titleOfInvention Udp-dependent glycosyltransferase for high efficiency production of rebaudiosides
abstract OHReb D OH Reb A OH OH FIG. A H O 00 O C (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 15 February 2018 (15.02.2018) WIP0 I PCT omit VIII °nolo III ll VIII VIII (10) International Publication Number WO 2018/031955 A3 (51) International Patent Classification: C12N 15/81 (2006.01) Cl 2N 9/10 (2006.01) A23L 2/60 (2006.01) Cl 2N 9/90 (2006.01) (21) International Application Number: PCT/US2017/046637 (22) International Filing Date: 11 August 2017 (11.08.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/374,408 12 August 2016 (12.08.2016) US (71) Applicant: AMYRIS, INC. [US/US]; 5885 Hollis Street, Suite 100, Emeryville, California 94608 (US). (72) Inventors: ZHAO, Lishan; c/o Amyris, Inc., 5885 Hollis Street, Suite 100, Emeryville, California 94608 (US). LI, Wenzong; c/o Amyris, Inc., 5885 Hollis Street, Emerville, California 94608 (US). WICHMANN, Gale; c/o Amyris, Inc., 5885 Hollis Street, Suite 100, Emeryville, Califor- nia 94608 (US). KHANKHOJE, Aditi; c/o Amyris, Inc., 5885 Hollis Street, Suite 100, Emeryville, California 94608 (US). GARCIA DE GONZALO, Chantal; c/o Amyris, Inc., 5885 Hollis Street, Suite 100, Emeryville, California 94608 (US). MAHATDEJKUL-MEADOWS, Tina; c/o Amyris, Inc., 5885 Hollis Street, Suite 100, Emeryville, Cal- ifornia 94608 (US). JACKSON, Shaina; c/o Amyris, Inc., 5885 Hollis Street, Suite 100, Emeryville, California 94608 (US). LEAVELL, Michael; c/o Amyris, Inc., 5885 Hol- lis Street, Suite 100, Emeryville, California 94608 (US). PLATT, Darren; c/o Amyris, Inc., 5885 Hollis Street, Suite 100, Emeryville, California 94608 (US). (54) Title: UDP-DEPENDENT GLYCOSYLTRANSFERASE FOR HIGH EFFICIENCY PRODUCTION OF REBAUDIOSIDES (57) : Provided herein are compositions and methods for improved production of steviol glycosides in a host cell. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding a Setaria italica UDP-gly- cosyltransferase 40087 or its variant UDP-glycosyltransferase. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding a UDP-glycosyltransferase sr.UGT_9252778, Bd_UGT10850, and/or Ob_UGT91B1_like. In some embodiments, the host cell further comprises one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing steviol glycosides in the host cell. The compositions and methods described herein provide an efficient route for the heterologous production of steviol glycosides, including but not limited to, rebaudioside D and rebaudioside M. [Continued on next page] WO 2018/031955 A3 MIDEDIMOMOIDEIREIHRMIOMMUMOMEfin (74) Agent: PATHAK, Rahul et al.; Squire Patton Boggs (US) LLP, 1801 Page Mill Road, Suite 110, Palo Alto, California 94304 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to the identity of the inventor (Rule 4.17(i)) as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(11)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) with sequence listing part of description (Rule 5.2(a)) (88) Date of publication of the international search report: 15 March 2018 (15.03.2018)
priorityDate 2016-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426382526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71773169
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4555
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4555

Total number of triples: 37.